Vascepa (icosapent ethyl)

In Stock

Vascepa (icosapent ethyl)

By
CHEMMEDIX

Original price was: $6,000.00.Current price is: $4,800.00.

Request this medicine

Vascepa (icosapent ethyl) is a prescription medicine used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia and as an adjunct to statin therapy to reduce the risk of of cardiovascular events.

Patients helped

Over 1.2 million patients reached
More than 11,000 patients helped
100% successful deliveries to 88 countries

We can help with your import documents

We are experts in import regulations.

Category:

Description

What is Vascepa (icosapent ethyl) for?

Vascepa (icosapent ethyl) is an ethyl ester of eicosapentaenoic acid (EPA) indicated as an adjunct therapy for adult patients with:

  • elevated triglyceride (TG) levels (≥ 150 mg/dL) and established cardiovascular disease or, diabetes mellitus and two or more additional risk factors for cardiovascular disease as an adjunct to maximally tolerated statin therapy.
  • severe (≥ 500 mg/dL) hypertriglyceridemia as an adjunct to diet.

Where has Vascepa (icosapent ethyl) been approved?

Vascepa (icosapent ethyl) has been approved by:

  • Food and Drug Administration (FDA), USA:
    • On July 27, 2012 to reduce triglyceride levels in adults with severe hypertriglyceridemia
    • On December 13, 2019 to reduce cardiovascular risk
  • Health Canada on January 2, 2020 to reduce cardiovascular risk
  • European Medicines Agency (EMA) on January 29, 2021 under the brand name Vazkepa to reduce cardiovascular risk

Reviews

There are no reviews yet.

Be the first to review “Vascepa (icosapent ethyl)”

Your email address will not be published. Required fields are marked *

Use the form to Request for this Medicine

Please enable JavaScript in your browser to complete this form.
Name
Are you a...